LS, previously known as ‘the forgotten disease’ for its rarity, is nowadays growing. Some studies have suggested that the reason for this increase is antibiotic resistance, changes in prescription patterns, or the increased efficiency of diagnostic technologies (
5). Other studies have reported the link between the use of non-steroidal anti-inflammatory drugs and steroids and the enhanced bacterial virulence and spread (
6). Previous studies have shown that LS occurs more frequently in children and young populations (
7). In its typical presentation, LS is followed by an oropharyngeal infection, associated with the presence of suppurative thrombophlebitis of IJV with metastatic septic emboli, and is usually caused by
Fusobacterium (
8). However, many variants of the syndrome have been described. A review of the literature showed atypical LS cases who were not related to oropharyngeal infection but were related to intra-abdominal or lower limb infection (
3). Different locations of the infection mostly caused by
F. necrophorum were reported, including a prostatic abscess with iliac vein thrombosis and a pulmonary abscess, left ovarian vein thrombosis, and vertebral osteomyelitis (
3). We presented a case of LS caused by
F. necrophorum, which was complicated with supra-hepatic vein thrombosis as well as lung, liver, and brain abscesses. Since the hepatic portal circulation exclusively drains the gastrointestinal tract, the source of our patient’s infection was probably the lower gastrointestinal tract. In fact,
F. necrophorum is known to be part of the commensal anaerobic floora in the caecum/vermiform appendix, colon, and rectum. In our case, imaging studies, tumor markers, and colonoscopy failed to identify any anatomic or functional abnormality of the gastrointestinal tract. Nevertheless, since the patient had a history of abdominal pain and diarrhea prior to admission and did not show other systemic illnesses, supra-hepatic vein thrombosis and the liver abscess were most probably due to a primary infection affecting the lower gastrointestinal tract.
The diagnosis of LS can be difficult, and is often prompted by the identification of
F. necrophorum in blood cultures. It requires a high degree of clinical suspicion along with data indicating thrombophlebitis, sepsis, or septic emboli (
5). Imaging finding help through the diagnostic process. The computed tomography scan is most useful for the diagnosis of abscesses since it shows edema of soft tissues, and even, vein thrombosis (
9).
The desired treatment for
Fusobacterium species in LS is aggressive antibiotics; a combination of intravenous penicillin and metronidazole is the most commonly used (
6). The overall treatment duration is typically four to six weeks (
3). The average time between the start of the treatment and the resolution of fever varies from eight to 12 days (
9). The use of anticoagulation therapy is still controversial. However, most researchers believe that anticoagulation should be used in cases of thrombophilia (
10) or extensive and severe thrombosis not responding to antibiotics (
6). In our case, we observed a complete recanalization of the hepatic vein without anticoagulation therapy. Along with antibiotics, surgical or radiological abscess drainage may be recommended, depending on the size of the abscess (
6).
The overall mortality rate of LS is difficult to estimate, but is high (up to 25%) and depends on the timing of antibiotic initiation (
3). Accordingly, early diagnosis and appropriate treatment are crucial to reduce the mortality rate of this disease.